Pneumocystis carinii pneumonia: a cluster of eleven cases

Insights

An unusual cluster of Pneumocystis pneumonia cases occurred, primarily in patients with lymphoma or leukemia. Evidence suggests potential person-to-person transmission, prompting isolation protocols.

Area of Science:

  • Infectious Diseases
  • Oncology
  • Immunology

Background:

  • Pneumocystis carinii pneumonia (PCP) is an opportunistic infection.
  • Patients with hematologic malignancies, particularly lymphoma and leukemia, are at increased risk.
  • Corticosteroid therapy can further compromise immune function, increasing susceptibility to PCP.

Purpose of the Study:

  • To investigate an unusual cluster of 11 PCP cases at Memorial Hospital.
  • To identify potential risk factors and transmission routes within this cluster.
  • To evaluate the role of underlying conditions and medical interventions in PCP development.

Main Methods:

  • Retrospective review of 11 PCP cases over a 3-month period.
  • Analysis of patient demographics, underlying diagnoses (lymphoma, leukemia, Hodgkin's disease), and treatments (corticosteroids).
  • Investigation of potential patient-to-patient or physician-to-patient transmission through contact tracing and serological testing (indirect immunofluorescence).

Main Results:

  • Ten of 11 patients had lymphoma or leukemia.
  • Seven patients had corticosteroid therapy reduced or stopped before PCP diagnosis.
  • Potential transmission suggested by close contact among pediatric patients and shared physician for adult patients; elevated antibody titers found in some healthcare workers.

Conclusions:

  • The cluster suggests possible communicability of Pneumocystis carinii pneumonia, particularly in immunocompromised individuals.
  • Close contact and shared healthcare providers may play a role in transmission.
  • Hospital isolation of suspected/proven PCP cases was implemented as a precautionary measure.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...